BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19704401)

  • 21. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
    Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
    J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2009 Aug; 31(4):467-74. PubMed ID: 19571775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.
    Tedesco-Silva H; Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Slade A; Schmouder R; Medina-Pestana JO
    Clin Transplant; 2010; 24(4):E116-23. PubMed ID: 20047618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation.
    Stracke S; Shipkova M; Mayer J; Keller F; Zarghom A; Yang L; Henne-Bruns D; Wieland E
    Clin Transplant; 2012; 26(1):57-66. PubMed ID: 21299636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?
    Abd Rahman AN; Tett SE; Staatz CE
    Clin Pharmacokinet; 2014 Mar; 53(3):227-245. PubMed ID: 24327238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Chinese Renal Allograft Recipients After Administration of EC-MPS.
    Chen B; Shao K; An HM; Shi HQ; Lu JQ; Zhai XH; Liu XX; Wang XH; Xu D; Zhou PJ
    J Clin Pharmacol; 2019 Apr; 59(4):578-589. PubMed ID: 30537048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which is more suitable for kidney transplantation at the early post-transplantation phase in China - low dosing or standard dosing of enteric-coated mycophenolate sodium?
    Ding C; Xue W; Tian P; Ding X; Pan X; Xiang H; Tian X; Li Y; Zheng J
    Int J Clin Pract Suppl; 2014 Apr; (181):10-6. PubMed ID: 24673714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase.
    Yao X; Huang H; Wei C; Chen Y; Peng W; Xie W; Chen J
    Ther Drug Monit; 2015 Aug; 37(4):516-23. PubMed ID: 25565669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
    Graff J; Scheuermann EH; Brandhorst G; Oellerich M; Gossmann J
    Ther Drug Monit; 2016 Jun; 38(3):388-92. PubMed ID: 26829599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
    de Winter BC; van Gelder T; Glander P; Cattaneo D; Tedesco-Silva H; Neumann I; Hilbrands L; van Hest RM; Pescovitz MD; Budde K; Mathot RA
    Clin Pharmacokinet; 2008; 47(12):827-38. PubMed ID: 19026038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited sampling strategy of mycophenolic acid in adult kidney transplant recipients: influence of the post-transplant period and the pharmacokinetic profile.
    Chaabane A; Aouam K; Ben Fredj N; Hammouda M; Chadly Z; El May M; Boughattas N; Skhiri H
    J Clin Pharmacol; 2013 Sep; 53(9):925-33. PubMed ID: 23813362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of mycophenolic acid exposure using a limited sampling strategy in renal transplant recipients.
    Li J; Liu Y; Huang J; Fu Q; Chen E; Liu L; Zhang R; Huang M; Wang C
    Am J Nephrol; 2013; 37(6):534-40. PubMed ID: 23689735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.
    Aouam K; Chadli Z; Hammouda M; Fredj NB; Aloui S; May ME; Boughattas N; Skhiri H; Chaabane A
    Ther Drug Monit; 2015 Aug; 37(4):524-30. PubMed ID: 25627405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration-Time Curve Estimation.
    Sobiak J; Resztak M
    Eur J Drug Metab Pharmacokinet; 2021 Nov; 46(6):721-742. PubMed ID: 34480746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
    Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
    J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.